HeartBeam, Inc.

HeartBeam, Inc.

BEAT·NASDAQ

$1.47

+8.1%
HealthcareMedical - Healthcare Information Services

HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based diagnostic software system to address the rapidly growing field of remote patient monitoring. The company was incorporated in 2015 and is headquartered in Santa Clara, California.

At a Glance

Live Snapshot
Market Cap$50.63M
EPS-0.6200
P/E Ratio-3.85
Earnings Date05/07/2026

beat

Other Financing Activities

Last Annual Value

16.59M

3-Year CAGR

1924%

5-Year CAGR

%

10-Year CAGR

28%

HeartBeam, Inc.

HeartBeam, Inc. Competitors Analysis of Other Financing Activities

BEAT · NASDAQ
CompanyOther Financing Activities
CAGR 3Y
CAGR 5Y
CAGR 10Y
BEAT logo
HeartBeam, Inc.
NASDAQ:BEAT
16.59M
N/AN/A27.8% 
0.00
N/AN/AN/A
-4.53M
N/AN/AN/A
0.00
N/AN/AN/A
TELA logo
TELA Bio, Inc.
NASDAQ:TELA
-205.00K
N/AN/AN/A
0.00
N/AN/AN/A
MNOV logo
MediciNova, Inc.
NASDAQ:MNOV
244.02K
N/AN/A10.8%
0.00
N/AN/AN/A
14.71B
5831.7%3865.4%N/A
0.00
N/AN/AN/A
31.25M
N/A215.5%N/A
HeartBeam, Inc.

HeartBeam, Inc. Fair Value Envelope

BEAT · NASDAQ

Our analysis suggests that BEAT has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $1.47, this represents a potential HIDDEN relative to our calculated worth for HeartBeam, Inc..

Intrinsic Value
Current Price: $1.47